Vernon Hills, IL, United States of America

Michael L Prunier


Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1995-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael L. Prunier: Innovator in Glucamine Chemistry

Introduction

Michael L. Prunier is a notable inventor based in Vernon Hills, IL (US). He has made significant contributions to the field of glucamine chemistry, holding a total of 5 patents. His work focuses on innovative processes that enhance the production and oxidation of N-substituted glucamines.

Latest Patents

Prunier's latest patents include the invention of salt forms of 6-n-butylamino-6-deoxy-α-L-sorbofuranose. This invention outlines a process for producing N-substituted glucamines, which involves oxidizing an N-substituted glucamine with an oxidizing microbe or extract. Additionally, it describes a method for reducing the oxidized N-substituted glucamine to an N-substituted-1-deoxynojirimycin. Furthermore, a one-pot process for producing N-substituted-1-deoxynojirimycin from D-glucose is disclosed. Another significant patent focuses on the microbial oxidation of N-substituted glucamines, reiterating the processes mentioned above.

Career Highlights

Michael L. Prunier has built a successful career at G.D. Searle & Company, where he has been instrumental in advancing research in glucamine chemistry. His innovative approaches have led to the development of new processes that are crucial for the pharmaceutical industry.

Collaborations

Throughout his career, Prunier has collaborated with notable colleagues, including Mike G. Scaros and Roy W. Grabner. These partnerships have fostered a collaborative environment that enhances the research and development of new chemical processes.

Conclusion

Michael L. Prunier is a distinguished inventor whose work in glucamine chemistry has led to significant advancements in the field. His innovative patents and collaborative efforts continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…